However, no correlation between age and ACE2 could be evidenced here in both human and mouse samples, suggesting that changes in TBS-soluble ACE2 are not directly related to age but rather to AD pathology, as supported by the correlations observed with Aβ and tau pathologies in human subjects. Here, MAPT is linked to Alzheimer disease.